{"product_id":"9781118679678","title":"Attrition in the Pharmaceutical Industry Reasons, Implications, and Pathways Forward","description":"\u003ch1\u003eAttrition in the Pharmaceutical Industry\u003c\/h1\u003e\u003ch2\u003eReasons, Implications, and Pathways Forward\u003c\/h2\u003e\u003ch3\u003eAlexander Alex | C. John Harris | Dennis A. Smith\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Pharmacology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003e\u003cb\u003eWith a focus on case studies of R\u0026amp;D programs in a variety of disease areas, the book highlights fundamental productivity issues the pharmaceutical industry has been facing and explores potential ways of improving research effectiveness and efficiency.\u003c\/b\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eTakes a comprehensive and holistic approach to the problems and potential solutions to drug compound attrition\u003c\/li\u003e \u003cli\u003eTackles a problem that adds billions of dollars to drug development programs and health care costs\u003c\/li\u003e \u003cli\u003eGuides discovery and development scientists through R\u0026amp;D stages, teaching requirements and reasons why drugs can fail\u003c\/li\u003e \u003cli\u003eDiscusses potential ways forward utilizing new approaches and opportunities to reduce attrition\u003c\/li\u003e \u003c\/ul\u003e\n\u003c\/div\u003e\u003cdiv\u003e \u003cp\u003e\u003cb\u003eAlexander Alex, Dr. rer. nat.\u003c\/b\u003e, is director of Evenor Consulting and has over 20 years' experience as consultant and as director and research fellow in drug discovery in the pharmaceutical industry.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eC. John Harris, PhD\u003c\/b\u003e, is the director of cjh Consultants and has a successful track record in drug discovery, research management, small company fund-raising and start-ups.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eDennis A. Smith, PhD\u003c\/b\u003e, is an independent consultant with a long track record in drug discovery and development with an emphasis on metabolism and safety. He has published four books, including \u003ci\u003ePharmacokinetics and Metabolism in Drug Design\u003c\/i\u003e (1st and 2nd editions) and \u003ci\u003eReactive Drug Metabolites\u003c\/i\u003e published by Wiley.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e02 December 2015\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781118679678\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e370\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e23.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44384829145228,"sku":"9781118679678","price":141.26,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781118679678_6ccdb51d-d6b8-4701-addd-c15cc5a03a27.jpg?v=1780173353","url":"https:\/\/fh90cf-fv.myshopify.com\/products\/9781118679678","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}